<DOC>
	<DOCNO>NCT01773083</DOCNO>
	<brief_summary>The purpose international multi-center double-blind randomize placebo-controlled trial determine effect nebulized heparin , compare placebo , number ventilator-free day day 28 , burn patient confirm inhalation trauma require mechanical ventilation .</brief_summary>
	<brief_title>Trial Nebulized Heparin Versus Placebo Inhalation Trauma</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Burns</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Informed consent Age &gt; 18 year Need invasive mechanical ventilation Confirmed inhalation trauma ( bronchoscopically ) &gt; 36 hour trauma Receiving invasive ventilation &gt; 24 hour Expected duration mechanical ventilation &lt; 24 hour Chronic obstructive pulmonary disease GOLD stage III IV Any history pulmonary hemorrhage past 3 month Any history significant bleeding disorder Known allergy heparin , include heparininduced thrombocytopenia Pregnancy breast feed Unlikely survive &gt; 72 hour Total body surface area ( TBSA ) &gt; 60 % Witnessed proven aspiration ( i.e. , confirmed bronchoscopy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Inhalation trauma</keyword>
	<keyword>pulmonary coagulopathy</keyword>
	<keyword>heparin nebulization</keyword>
	<keyword>mechanical ventilation</keyword>
</DOC>